Kenterin

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameKenterin
Drug Alias NamekenterinEnterin-01ENT-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynuclein alpha inhibitors
TargetsSynuclein alpha
Therapy Area/IndicationsConstipationDementiaParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnterin Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnterin Inc
Inactive CompaniesN/A
Active IndicationsConstipationParkinson Disease
Inactive IndicationsDementia

Other Information

ATC CodeN/A
Related LinksN/A